From Hope to Silence: The Hidden Stories of 128,127 Patients in Discontinued and Unpublished Obesity Trials
The growing and ongoing obsession for treating obesity has led to the use of diabetic treatment injections to try and cure this disease. Anti-diabetic drugs (e.g., Liraglutide/Saxenda, Ozempic, Metformin and Mounjaro) have shown promising weight-loss results in clinical settings. Our study analyzes the discontinuation and non-publication of clinical trials concerning the use of diabetes injections (GLP-1 Agonists) in treating obesity.
Publication Details
- Journal
- Egyptian Society of Diabetes and Lipidology Journal
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21608/esdlj.2025.456296
- Primary Topic
- Obesity and Health Practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00